BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23423260)

  • 1. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.
    Pepper RJ; Hamour S; Chavele KM; Todd SK; Rasmussen N; Flint S; Lyons PA; Smith KG; Pusey CD; Cook HT; Salama AD
    Kidney Int; 2013 Jun; 83(6):1150-8. PubMed ID: 23423260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
    Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
    Front Immunol; 2021; 12():737708. PubMed ID: 34759920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
    Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
    Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.
    Naidu GS; Sharma A; Nada R; Kohli HS; Jha V; Gupta KL; Sakhuja V; Rathi M
    Rheumatol Int; 2014 Dec; 34(12):1721-7. PubMed ID: 24838685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of citrullinated histone H3-positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody-associated vasculitis.
    Kimura H; Mii A; Shoji J; Arakawa Y; Shimizu A
    Histopathology; 2021 Mar; 78(4):520-531. PubMed ID: 32956514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Pepper RJ; Draibe JB; Caplin B; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; Monach PA; Seo P; Spiera R; William St Clair E; Tchao NK; Stone JH; Specks U; Merkel PA; Salama AD;
    Arthritis Rheumatol; 2017 Jan; 69(1):185-193. PubMed ID: 27428710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis.
    Martinez Valenzuela L; Draibe J; Quero Ramos M; Fulladosa Oliveras X; Melilli E; Cruzado Garrit JM; Torras Ambrós J
    PLoS One; 2018; 13(10):e0205982. PubMed ID: 30347000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
    Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.